I think the progress is slow because the product is low price. They need a massive volume to make significant revenue.
They are burning cash at $1.0 per qtr and only have $1.5 cash. So I agree with elitelifestyles that a CR is most likely imminent.
The Medical Cannabis initiative appears subdued.
I have held the stock, been out, back in and currently out. I like the product and concept but just waiting to see the financial economics of the business stack up.
- Forums
- ASX - By Stock
- Ann: Appendix 4C - quarterly
I think the progress is slow because the product is low price....
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)